FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2121569332> ?p ?o ?g. }

• W2121569332 endingPage "92" @default.
• W2121569332 startingPage "86" @default.
• W2121569332 abstract "Back to table of contents Previous article Next article REGULARFull AccessThe Neuropsychiatry and Neuropsychology Of Lipoid ProteinosisHelena B. Thornton Ph.D.Daan Nel Ph.D.Dorothy Thornton Ph.D.Jack van Honk Ph.D.Gus A. Baker Ph.D.Dan J. Stein M.D., Ph.D.Helena B. Thornton Ph.D.Search for more papers by this authorDaan Nel Ph.D.Search for more papers by this authorDorothy Thornton Ph.D.Search for more papers by this authorJack van Honk Ph.D.Search for more papers by this authorGus A. Baker Ph.D.Search for more papers by this authorDan J. Stein M.D., Ph.D.Search for more papers by this authorPublished Online:1 Jan 2008AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail L ipoid proteinosis, also known as Hyalinosis cutis et mucosae or Urbach-Wiethe Disease, is a rare hereditary disorder transmitted by an autosomal recessive gene. 1 – 2 From the time Urbach and Wiethe 3 gave the first clear description of the disease, a cumulative total of 250 1 to 300 cases 4 – 6 have been reported in the literature. The disorder is a systemic illness characterized by depositions of storage material in the mucous membranes. 4 , 7 – 11 The most classic symptoms are hoarseness of speech, often from birth or infancy, 7 , 12 and skin lesions. 12 – 14 There is considerable clinical variability among lipoid proteinosis subjects 2 and lesions may increase in severity and extent with age. 15 The most consistent clinical features for a diagnosis have been a hoarse voice and a thickened sublingual frenulum leading to restricted tongue movement. 2 Bilateral, circumscribed, and symmetrical calcification in the medial temporal regions are common 4 , 9 , 16 – 17 and are associated with neuropsychiatric sequelea including seizure disorder 9 , 16 , 18 and psychotic symptoms. 6 , 19 – 20 Medial temporal regions encompass the amygdala and studies on patients with lipoid proteinosis contributed to our understanding of the role of the amygdala in fear processing and social cognition. 17 , 21 – 26 The lipoid proteinosis subjects of Adolphs et al. 21 and Calder and Young 27 showed significant impairment in recognizing fearful expressions, although individual performances ranged from severely impaired to essentially normal. In addition, while most subjects were impaired in recognizing other negative expressions in addition to fear, they were not impaired in recognizing happy expressions. Lipoid proteinosis has been associated with difficulty in coping with emotionally loaded memory 28 , 29 and impaired executive control over social behavior. 17 There has, however, been significant variability in neuropsychiatric and neuropsychological findings across studies. In some studies there has been no evidence of psychiatric symptomatology. 30 – 32 Siebert et al. 28 studied 10 people with lipoid proteinosis, six with bilateral calcification of the amygdaloid complex, and did not find that lipoid proteinosis necessarily impaired the recognition of basic emotions such as fear and anger. Lipoid proteinosis has been associated with both intact intelligence 9 , 17 , 20 , 30 , 33 and mental retardation. 14 , 16 , 34 – 36 While there is true heterogeneity within the lipoid proteinosis population, 2 which may represent a variable and slowly progressive degenerative process in the brain, 28 some of the variation across the studies may be explicable on the basis of relatively small sample sizes and other methodological problems (e.g., different methods of assessing symptomatology). The current study is, to our knowledge, the largest systematic study of psychiatric diagnosis and neuropsychological measures in lipoid proteinosis. In view of evidence of amygdala pathology and prior findings of associated neuropsychiatric impairment, we hypothesized that this population would be characterized by increased rates of mood and anxiety disorders and impairments in processing emotional expressions. METHODThirty-four adult South African subjects with lipoid proteinosis (ages 17–63 years) participated in this study. Two were patients attending a large state hospital in Cape Town, five were from the greater Johannesburg, South Africa/Pretoria area, and 27 lived in the impoverished and rural Northern Cape. Forty-seven controls from the Northern Cape (matched for home language, socioeconomic status, age, and matched as closely as possible for years of education and gender) completed the same batteries. Ethics approval was obtained from the University of Stellenbosch, Tygerberg Hospital, and abided by the Helsinki, Finland, declaration guidelines of “good clinical practice.” All subjects gave informed consent. Six participants (two with lipoid proteinosis and four matched controls) were 17 years old and they and their guardians gave consent. Three children with lipoid proteinosis under 16 years were excluded from this study. The diagnosis of lipoid proteinosis was established through genetic and clinical means. Subjects were examined by use of standardized neuropsychiatric and neuropsychological measures. The battery was designed to assess neuropsychiatric symptoms and neuropsychological dysfunction previously reported in the literature in association with lipoid proteinosis (e.g., psychosis, depression, problems with emotional recognition, and memory and executive functioning). Tests were not administered if the subjects were unable to complete them validly (e.g., due to psychosis or illiteracy). Subjects were assessed in their home language on the following neuropsychiatric measures: Mini International Neuropsychiatric Interview (MINI+), 37 Positive and Negative Syndrome Scale (PANSS), 38 and Montgomery-Asberg Depression Rating Scale (MADRS). 39 They were assessed on neuropsychological measures including the Wechsler Abbreviated Scale of Intelligence (WASI) except for the vocabulary subtest. 40 This was substituted with the vocabulary subtest from the WAIS-III scaled score, using the Human Sciences Research Council of South Africa’s Afrikaans translation and adaptations for South Africa. 41 Two people with lipoid proteinosis had already completed the South African Wechsler Intelligence Scale-Revised (SAWAIS-R) and did not do the WASI. 42 Subjects were also assessed with the Benton Facial Recognition (short form) 43 and the Ekman Facial Emotional Recognition. 44 This test consists of 110 photographs of people displaying either a neutral expression or one of six emotions (happiness, sadness, fear, anger, surprise, or disgust). Subjects must try and match one of the seven options to the expression they see. In addition, subjects were assessed with the Controlled Oral Word Association Test (COWAT); the Rey Auditory Verbal Learning Task (RAVLT); subtests from the Wechsler Memory Scale—Revised, 45 including Logical Memory, translated into Afrikaans with the names changed to local geographical settings (e.g., Okiep instead of Boston); Complex Figure of Rey (Copy and Immediate Incidental Recall); draw a clock; Hooper Visual Organization Task; Trail Making Tests A and B; and the Ruff Figural Fluency Test. Statistical Analysis As exemplified in the Table 1 vignettes, the Northern Cape subjects differed significantly from the non-Northern Cape lipoid proteinosis patients on a number of demographic parameters (i.e., years of education, level of employment). Thus non- Northern Cape lipoid proteinosis subjects were excluded from further neuropsychiatric and neuropsychological analyses. Data from Northern Cape lipoid proteinosis subjects and controls were compared with analysis of variance (ANOVA) when normally distributed and with Mann-Whitney analyses when not normally distributed. Significance was set at p<0.05. TABLE 1. VignettesTABLE 1. VignettesEnlarge tableRESULTS In the Northern Cape lipoid proteinosis group (N=27), there were 12 males (44.4%) and 15 females (55.6%) ( Table 2 ). The mean age was 36.89 years (SD=14.0), the mean education was 8.37 years (SD=3.2), and less than 12% were in full-time employment. The Northern Cape control group had 20 males (42.6%) and 27 females (57.4%), with a mean age of 36.51 years (SD=14.2) and a mean education of 8.94 years (SD=2.93), and 10.6% were in full-time employment. Twenty-seven percent (27%) of the Northern Cape lipoid proteinosis group reported seizures. TABLE 2. Demographics (Matching Gender, Age, and Education)TABLE 2. Demographics (Matching Gender, Age, and Education)Enlarge table Neuropsychiatric diagnoses were compared in lipoid proteinosis subjects from the Northern Cape (N=27) and controls (N=47). In the Northern Cape lipoid proteinosis group, anxiety disorders (33%), mood disorders (33%), psychosis (22%), and schizophrenia (15%) were common ( Table 3 ), and in all cases significantly more prevalent than in the control group (p<0.01). Similarly, the Northern Cape lipoid proteinosis group was significantly more likely to have higher scores on the MADRS and on the negative symptoms scale of the PANSS. There was no significant difference between the groups for alcohol abuse (26% in both); 58% of lipoid proteinosis and 60% of control adult men abused alcohol (MINI+). Adults with lipoid proteinosis were significantly less likely to live with partners or to have children. TABLE 3. Neuropsychiatric Diagnoses in Northern Cape Lipoid Proteinosis and Northern Cape Controls According to the MINI+TABLE 3. Neuropsychiatric Diagnoses in Northern Cape Lipoid Proteinosis and Northern Cape Controls According to the MINI+Enlarge table The mean IQ for both the Northern Cape lipoid proteinosis subjects and the Northern Cape controls (including many educationally deprived participants) was markedly poorer than established norms ( Table 4 ). When comparing the lipoid proteinosis to the control subjects the following was evident: of the three WASI tests and Vocabulary test from the WAIS-III, only Similarities was significantly different between the two groups (controls significantly better than lipoid proteinosis subjects). TABLE 4. Northern Cape Neuropsychology Tests: LiP versus ControlsTABLE 4. Northern Cape Neuropsychology Tests: LiP versus ControlsEnlarge table Northern Cape lipoid proteinosis subjects were significantly less likely to recognize correctly the emotional expressions—fear, anger, disgust, surprise, sadness, happiness and neutrality—than the matched Northern Cape controls ( Table 5 ). On basic face recognition, there were no significant differences on the Benton Facial Recognition Test, unless presented with less lighting or from a different angle. In terms of neuropsychological testing, there were no significant differences across Northern Cape lipoid proteinosis subjects and controls for the two tests of language (COWAT and Vocabulary, WAIS-III). However, the Northern Cape lipoid proteinosis group scored significantly worse than controls on several tests of memory, including digits forward and backward, auditory new learning on RAVLT, retention after distraction, the recognition task, the number of repetitions in new learning, both immediate and delayed paragraph recall, as well as the percentage of the story that was retained, and delayed recall of the visual reproduction designs. There were no significant differences in either the forewarned or incidental immediate visual recall tasks ( Table 4 ). TABLE 5. Emotional RecognitionTABLE 5. Emotional RecognitionEnlarge table On selected executive tasks, there were no significant differences on tests of planning (draw a clock, copy of complex figure, WASI Matrices, or block design) between the Northern Cape lipoid proteinosis group and controls, although the Northern Cape lipoid proteinosis group did significantly worse on visual organization ( Table 4 ). However, for tasks of design fluency, switching and dual sequencing, and abstract thinking, the control group performed significantly better. Thus, controls performed significantly better than Northern Cape lipoid proteinosis subjects on memory and specific executive abilities (design initiation, switching, visual organization, and abstract thinking), but language tasks and other executive skills (planning) appeared unaffected by lipoid proteinosis. DISCUSSION These findings represent the largest report to date of neuropsychiatric and neuropsychological data in people with lipoid proteinosis. Compared with controls, a sample of people with lipoid proteinosis in the Northern Cape had increased rates of mood, anxiety, and psychotic disorders as well as greater symptom severity, a decreased ability to identify both positive and negative emotional expressions, and significant impairment on memory and executive (specifically design fluency, switching, and abstract thinking) functions. The findings here confirm many of the observations made in previous reports on neuropsychiatric symptoms and neuropsychological impairment in smaller groups of lipoid proteinosis subjects. 21 – 27 A larger sample provides us with some additional information; for example, we were able to demonstrate that there is impairment not only in processing of negative emotions, but also in processing of positive emotions in lipoid proteinosis. It can be hypothesized that such deficits have a significant impact on functioning in lipoid proteinosis. Nevertheless, we noted that the people with lipoid proteinosis were able to interact appropriately with us, possibly suggesting the presence of compensatory mechanisms. 28 However, the negative impact of impaired cognitive and affective processing may help explain why lipoid proteinosis patients were less likely to be living with partners and had fewer children than controls. There are only occasional inconsistencies between our data and those reported previously. One report did not find memory or executive difficulties in lipoid proteinosis. 28 This may well reflect restriction of that sample to subjects with IQ predominantly in the average to above average ranges. Indeed, the overall picture of lipoid proteinosis described here is also consistent with previous findings of marked inter-individual variability within the lipoid proteinosis population, perhaps reflecting differences in extent of intracranial calcification in this condition 7 or in the extent of comorbid seizures (although we did not find significant differences in those with and without seizures). It is also worth considering psychosocial contributors to variance in the data here. We noted significant difference in intelligence and education between lipoid proteinosis subjects living in the relatively impoverished Northern Cape and a smaller group who lived elsewhere. Indeed, notable findings here included the high prevalence of alcohol abuse and low neuropsychological performance of normal controls living in the Northern Cape. Much remains to be done in this setting in order to reverse current psychosocial circumstances and their negative impact on mental health. The amygdala plays a key role in mediating emotional responses, 17 , 19 , 21 , 27 particularly those related to possible danger and threat. 23 – 26 The amygdala is also important in the modulation of attention, perception, learning, and memory, 46 , 47 as well as in a number of different psychopathologies. 48 – 53 The data here on neuropsychological dysfunction, as well as increased psychotic, mood, and anxiety disorders, is consistent with temporal involvement and with the known high prevalence of temporal calcifications in lipoid proteinosis. 9 , 16 , 19 , 28 , 31 Patients in the current study live in remote rural areas and brain imaging was not available; such work could in the future shed more light on the findings here. Received October 8, 2005; revised January 12, 2007; accepted January 18, 2007. Drs. Thornton and Stein are affiliated with the Departments of Psychiatry, University of Stellenbosch and University of Cape Town, South Africa. Dr. Nel is affiliated with the Centre for Statistical Consultation, University of Stellenbosch, South Africa. Dr.Thornton is affiliated with the School of Public Health, University of California, Berkeley, California. Dr. van Honk is affiliated with the Helm Holtz Institute, Utrecht University, The Netherlands. Dr. Baker is affiliated with the Division of Neurosciences, University of Liverpool, United Kingdom. Address correspondence to Dr. Thornton, Department of Psychiatry, University of Cape Town, Private Bag X1, Observatory 7925, Cape Town, South Africa; [email protected] (e-mail).Copyright © 2008 American Psychiatric Publishing, Inc.References1 . Hamada T, McLean WH, Ramsay M, et al: Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (EMC1). Hum Mol Genet 2002; 11:833–840Google Scholar2 . Van Hougenhouck-Tulleken W, Chan I, Hamada T, et al: Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa. Br J Dermatol 2004; 151:413–423Google Scholar3 . Urbach E, Wiethe C: Lipidosis cutis et mucosae. Virchows Arch Pathol Anat Physiol Klin Med 1929; 273:285–319Google Scholar4 . Aroni K, Lazaris AC, Papadimitriou K, et al: Lipoid proteinosis of the oral mucosa: case report and review of the literature. Pathol Res Pract 1998; 194:844–859Google Scholar5 . Botha MC, Beighton P: Inherited disorders in the Afrikaner population in southern Africa, part II: skeletal, dermal and hematological conditions; the Afrikaners of Gamkaskloof; demographic considerations. S Afr Med J 1983; 64:664–667Google Scholar6 . Cote DN: Head and neck manifestations of lipoid proteinosis. Otolaryngol Head Neck Surg 1998; 119:144–145Google Scholar7 . Hofer P: Urbach-Wiethe disease (lipoglycoproteinosis; lipoid proteinosis; hyalinosis cutis et mucosae): a clinco-genetic study of 14 families from northern Sweden. Hereditas 1974; 77:209–218Google Scholar8 . Costagliola C, Verolino M, Landolfo P, et al: Lipoid proteinosis (Urbach-Wiethe disease). Ophthalmologica 1999; 213:392–396Google Scholar9 . Newton H, Rosenberg RN, Lampert PW, et al: Neurological involvement in Urbach-Wiethe’s disease (lipoid proteinosis). Neurology 1971; 21:1205–1213Google Scholar10 . Caccamo D, Jaen A, Telenta M, et al: Lipoid proteinosis of the small bowel. Arch Pathol Lab Med 1994; 118:572–574Google Scholar11 . Bazopoulou-Kyrkanidou E, Tosios KI, Zabelis G, et al: Case report: hyalinosis cutis et mucosae: gingival involvement. J Oral Pathol Med 1998; 27:233–237Google Scholar12 . Desmet S, Devos SA, Chan I, et al: Clinical and molecular abnormalities in lipoid proteinosis. Eur J Dermatol 2005; 15:344–346Google Scholar13 . Chan I: The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol 2004; 29:52–56Google Scholar14 . Teive HA, Pereira ER, Zavala JA, et al: Generalized dystonia and striatal calcifications with lipoid proteinosis. Neurology 2004; 63:2168–2169Google Scholar15 . Feiler-Ofry V, Lewy A, Regenbogen L, et al: Lipoid proteinosis (Urbach-Wiethe syndrome). Br J Ophthalmol 1979; 63:694–698Google Scholar16 . Hofer PA: Urbach-Wiethe disease (lipoglycoproteinosis); lipoid proteinosis; hyalinosis et mucosae: a review. Acta Derm Venerol 1973; 53(suppl 71):1–52Google Scholar17 . Tranel D, Hyman BT: Neuropsychological correlates of bilateral amygdala damage. Arch Neurol 1990; 47:349–355Google Scholar18 . Heyl T: Lipoid proteinosis: the clinical picture. Br J Dermatol 1963; 75:465–472Google Scholar19 . Emsley R, Pastor L: Lipoid proteinosis presenting with neuropsychiatric manifestations. J Neurol Neurosurg Psychiatry 1985; 48:1290–1292Google Scholar20 . Kleinert R, Cervos-Navarro J, Kleinert G, et al: Predominantly cerebral manifestation in Urbach-Wiethe’s syndrome (lipoid proteinosis cutis et mucosae): a clinical and pathomorphological study. Clin Neuropathol 1987; 6:43–45Google Scholar21 . Adolphs R, Tranel D, Hamann S, et al: Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia 1999; 37:1111–1117Google Scholar22 . Bechara A, Tranel D, Damasio H, et al: Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 1995; 269:1115–1118Google Scholar23 . Adolphs R, Damasio H, Tranel D, et al: Cortical systems for the recognition of emotion in facial expressions. J Neurosci 1996; 16:7678–7687Google Scholar24 . Adolphs R, Tranel D, Damasio H, et al: Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 1994; 372:669–672Google Scholar25 . Adolphs R, Tranel D, Damasio H, et al: Fear and the human amygdala. J Neurosci 1995; 15:5879–5891Google Scholar26 . Adolphs R, Tranel D: Amygdala damage impairs emotion recognition from scenes only when they contain facial expressions. Neuropsychologia 2003; 41:1281–1289Google Scholar27 . Calder AJ, Young AW: Facial emotion recognition after bilateral amygdala damage: differently severe impairment of fear. Cogn Neuropsychology 1996; 13:699–745Google Scholar28 . Siebert M, Markowitsch HJ, Bartel P: Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 2003; 126:1–11Google Scholar29 . Cahill L, Babinsky R, Markowitsch HJ, et al: The amygdala and emotional memory. Nature 1995; 377:295–296Google Scholar30 . Van Rooy CH, Swart JG, Pietrzak JT: Lipoidproteinosis: a report of four cases. S Afr Med J 1991; 79:160–162 (Afrikaans)Google Scholar31 . Hofer PA: Urbach-Wiethe disease (lipoglycoproteinosis; lipoid proteinosis; hyalinosis cutis et mucosae): a clinical-genetic study of 14 families from northern Sweden. Hereditas 1974; 7:209–218Google Scholar32 . Botha P: Oral lipoid proteinosis. SADJ 1999; 54:371–373Google Scholar33 . Özbek SS, Akyar S, Turgay M: Case report: computed tomography findings in lipoid proteinosis: report of two cases. Br J Radiol 1994; 67:207–209Google Scholar34 . Böhme M, Wahlgren CF: Lipoid proteinosis in three children. Acta Paediatr 1996; 85:1003–1005Google Scholar35 . Izaki M, Horiuchi T, Hozaki H: Lipoidosis cutis et mucosae (lipoid proteinosis Urbach-Wiethe): report of a case. Keio J Med 1954; 3:163–177Google Scholar36 . Grosfeld JCM, Spaas J, Van de Staak WJBM, et al: Hyalinosis cutis et mucosae. Dermatologica (Basel) 1965; 130:239–266Google Scholar37 . Sheehan D, Janavs J, Baker RM, et al: Mini International Neuropsychiatric Inventory Plus. Tampa, University of South Florida, 2003Google Scholar38 . Kay SR, Opler LA, Lindenmayer JP: The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989; 155:59–65Google Scholar39 . Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382–389Google Scholar40 . The Psychological Corporation: Wechsler Abbreviated Scale of Intelligence: Manual. San Antonio, TX, Harcourt Brace Jovanovich, 1999Google Scholar41 . Claasen NCW, Krynauw AH, Paterson H, et al: A Standardisation of the WAIS-III for English-Speaking South Africans. Pretoria, South Africa, Human Sciences Research Council, 2001Google Scholar42 . Human Sciences Research Council: South African Wechsler Adult Intelligence Scale. Johannesburg, South Africa, Human Sciences Research Council, 1983Google Scholar43 . Benton AL, Sivan AB, Hamsher K de S, et al: Facial Recognition: Stimulus and Multiple Choice Pictures. Oxford, Oxford University Press, 1983Google Scholar44 . Ekman P, Friesen WV: Pictures of Facial Affect. Palo Alto, Calif, Consulting Psychologists Press, 1976Google Scholar45 . Wechsler D: Wechsler Memory Scale–Revised: Manual. San Antonio, TX, Psychological Corp., 1987Google Scholar46 . Aggleton JP (ed): The Amygdala: A Functional Analysis, 2nd ed. Oxford, Oxford University Press, 2001Google Scholar47 . Baxter MG, Murray EA: The amygdala and reward. Neuroscience 2002; 3:563–573Google Scholar48 . Baron-Cohen S: Mindblindness: An Essay on Autism and Theory of Mind. Cambridge, MA, MIT Press, 1995Google Scholar49 . Baron-Cohen S, Ring HA, Bullmore ET, et al: The amygdala theory of autism. Neurosci Behav Rev 2000; 24:355–364Google Scholar50 . Fudge JL, Powers JM, Habner SN, et al: Considering the role of the amygdala in psychotic illness: a clinicopathological correlation. J Neuropsychiatry Clin Neurosci 1998; 10:383–394Google Scholar51 . Evangeli M, Broks P: Face processing in schizophrenia: parallels with the effects of amygdala damage. Cogn Neuropsychiatry 2000; 5:81–105Google Scholar52 . Sachdev P, Brodaty H, Cheang D: Hippocampus and amygdala volumes in elderly schizophrenic patients as assessed by magnetic resonance imaging. Psychiatry Clin Neurosci 2000; 54:105–113Google Scholar53 . Haber SN, Fudge JL: The interface between dopamine neurones and the amygdala: implications for schizophrenia. Schizophr Bull 1997; 23:471–482Google Scholar FiguresReferencesCited byDetailsCited byUrbach-Wiethe disease in a young patient without apparent amygdala calcificationNeuropsychologia, Vol. 183Cranial magnetic resonance imaging findings and their relationship with neuropsychiatric findings in adult patients with lipoid proteinosis7 March 2022 | Gulhane Medical Journal, Vol. 64, No. 1Urbach--Wiethe disease: A rare cause of bilateral mesial temporal lobe involvement and cerebral hemorrhageAnnals of Indian Academy of Neurology, Vol. 25, No. 3Neuropathological Level of TrustTrust and Lesion EvidenceRoles of the bed nucleus of the stria terminalis and amygdala in fear reactionsAnthropomorphizing without Social Cues Requires the Basolateral AmygdalaJournal of Cognitive Neuroscience, Vol. 31, No. 4Journal of Substance Use, Vol. 24, No. 4Clinical EEG and Neuroscience, Vol. 49, No. 3Cortex, Vol. 88Journal of Voice, Vol. 31, No. 1The role of the basolateral amygdala in the perception of faces in natural contexts5 May 2016 | Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 371, No. 1693Journal of Neuroscience Research, Vol. 94, No. 6Cortex, Vol. 81, Vol. 132Structural Focal Temporal Lobe Seizures in a Child With LipoproteinosisPediatric Neurology, Vol. 52, No. 1Cortex, Vol. 52Neurobiology of Learning and Memory, Vol. 112Generous economic investments after basolateral amygdala damage22 January 2013 | Proceedings of the National Academy of Sciences, Vol. 110, No. 7Hypervigilance for fear after basolateral amygdala damage in humans15 May 2012 | Translational Psychiatry, Vol. 2, No. 5King Saud University Journal of Dental Sciences, Vol. 3, No. 1Social Cognitive and Affective Neuroscience, Vol. 7, No. 5The World Journal of Biological Psychiatry, Vol. 13, No. 1Molecular and neurological characterizations of three Saudi families with lipoid proteinosis24 February 2011 | BMC Medical Genetics, Vol. 12, No. 1Reprint of: Fear-enhanced visual search persists after amygdala lesionsNeuropsychologia, Vol. 49, No. 4Neuropsychologia, Vol. 49, No. 4Journal of Neurodevelopmental Disorders, Vol. 2, No. 3Neuropsychologia, Vol. 48, No. 12 Volume 20Issue 1 Winter, 2008Pages 86-92 Metrics PDF download History Published online 1 January 2008 Published in print 1 January 2008" @default.
• W2121569332 created "2016-06-24" @default.
• W2121569332 creator A5016324896 @default.
• W2121569332 creator A5035153754 @default.
• W2121569332 creator A5038003929 @default.
• W2121569332 creator A5048398907 @default.
• W2121569332 creator A5073216705 @default.
• W2121569332 creator A5087359497 @default.
• W2121569332 date "2008-01-01" @default.
• W2121569332 modified "2023-10-17" @default.
• W2121569332 title "The Neuropsychiatry and Neuropsychology Of Lipoid Proteinosis" @default.
• W2121569332 cites W141581154 @default.
• W2121569332 cites W1488926069 @default.
• W2121569332 cites W1492041649 @default.
• W2121569332 cites W1492853662 @default.
• W2121569332 cites W1499778067 @default.
• W2121569332 cites W1499842031 @default.
• W2121569332 cites W1509863986 @default.
• W2121569332 cites W1510044868 @default.
• W2121569332 cites W1520120420 @default.
• W2121569332 cites W1537969773 @default.
• W2121569332 cites W1540816832 @default.
• W2121569332 cites W1555724755 @default.
• W2121569332 cites W1557296464 @default.
• W2121569332 cites W1587001415 @default.
• W2121569332 cites W1593576966 @default.
• W2121569332 cites W1597217152 @default.
• W2121569332 cites W1598800837 @default.
• W2121569332 cites W1608785134 @default.
• W2121569332 cites W1688754235 @default.
• W2121569332 cites W1700484054 @default.
• W2121569332 cites W1758538055 @default.
• W2121569332 cites W179191146 @default.
• W2121569332 cites W1898077687 @default.
• W2121569332 cites W1963681078 @default.
• W2121569332 cites W1963945289 @default.
• W2121569332 cites W1964722968 @default.
• W2121569332 cites W1966096993 @default.
• W2121569332 cites W1969227269 @default.
• W2121569332 cites W1969751695 @default.
• W2121569332 cites W1971267280 @default.
• W2121569332 cites W1974184001 @default.
• W2121569332 cites W1974214490 @default.
• W2121569332 cites W1975570616 @default.
• W2121569332 cites W1975853990 @default.
• W2121569332 cites W1976131491 @default.
• W2121569332 cites W1976795320 @default.
• W2121569332 cites W1977727135 @default.
• W2121569332 cites W1978155128 @default.
• W2121569332 cites W1981569341 @default.
• W2121569332 cites W1982053611 @default.
• W2121569332 cites W1985164067 @default.
• W2121569332 cites W1986620970 @default.
• W2121569332 cites W1989283066 @default.
• W2121569332 cites W1990304863 @default.
• W2121569332 cites W1990359720 @default.
• W2121569332 cites W1990561576 @default.
• W2121569332 cites W1993924263 @default.
• W2121569332 cites W1995383486 @default.
• W2121569332 cites W1997402124 @default.
• W2121569332 cites W2004187698 @default.
• W2121569332 cites W2007316161 @default.
• W2121569332 cites W2007431552 @default.
• W2121569332 cites W2009634691 @default.
• W2121569332 cites W2012682481 @default.
• W2121569332 cites W2012901722 @default.
• W2121569332 cites W2013700562 @default.
• W2121569332 cites W2014379657 @default.
• W2121569332 cites W2014388836 @default.
• W2121569332 cites W2014507718 @default.
• W2121569332 cites W2016909901 @default.
• W2121569332 cites W2019111214 @default.
• W2121569332 cites W2020577301 @default.
• W2121569332 cites W2022478256 @default.
• W2121569332 cites W2023771120 @default.
• W2121569332 cites W2025411412 @default.
• W2121569332 cites W2028038005 @default.
• W2121569332 cites W2030609855 @default.
• W2121569332 cites W2032585700 @default.
• W2121569332 cites W2034443061 @default.
• W2121569332 cites W2034883925 @default.
• W2121569332 cites W2035518691 @default.
• W2121569332 cites W2035535796 @default.
• W2121569332 cites W2036019952 @default.
• W2121569332 cites W2036864487 @default.
• W2121569332 cites W2038918477 @default.
• W2121569332 cites W2041197933 @default.
• W2121569332 cites W2042475802 @default.
• W2121569332 cites W2042649681 @default.
• W2121569332 cites W2042913860 @default.
• W2121569332 cites W2043292745 @default.
• W2121569332 cites W2043813045 @default.
• W2121569332 cites W2044071327 @default.
• W2121569332 cites W2045001730 @default.
• W2121569332 cites W2045122726 @default.
• W2121569332 cites W2047172322 @default.
• W2121569332 cites W2047357139 @default.
• W2121569332 cites W2047990446 @default.

• next